Fifty years ago, a child diagnosed with acute lymphoblastic leukemia (ALL), the most common type of pediatric cancer, had little to no chance of survival. Today, those odds have increased dramatically thanks to tremendous advances in chemotherapy and other treatments. Cure rates for this type of leukemia can reach as high as 90 percent. Yet, there is … Continue reading Demethylating Agent May Boost Chemotherapy Effectiveness for Specific Type of Childhood Leukemia
Warning: Chemo may be linked to cancer relapses in patients with leukemia
It’s incredibly devastating to experience a relapse after cancer goes into remission, but for patients with acute lymphoblastic leukemia (ALL), the possibility is all too real. In fact, as many as 1 in 5 kids who undergo chemotherapy for the disease will relapse, even if they were in complete remission, and now it appears that the … Continue reading Warning: Chemo may be linked to cancer relapses in patients with leukemia
Children treated for acute lymphoblastic leukemia may grow up to have heart problems, study finds
Acute lymphoblastic leukemia (ALL) is a type of cancer that affects the blood and bone marrow. It is the most common type of cancer developed by children. Although ALL is known to progress quickly, advances in modern medicine have increased the survival rate of children with this disease. However, a recent study by researchers from the Medical University … Continue reading Children treated for acute lymphoblastic leukemia may grow up to have heart problems, study finds
Intermittent fasting inhibits the most common type of childhood leukemia
Intermittent fasting is all the rage right now; it’s been credited with a host of health benefits and heralded as the next big thing in weight loss. The more intermittent fasting (IF) is studied, the more impressive it seems to become: Recent research has shown that fasting regularly, as one does with IF, can actually kill cancer … Continue reading Intermittent fasting inhibits the most common type of childhood leukemia
Dr. Eddy Bettermann MD 